STAT September 28, 2023
Damian Garde and Allison DeAngelis

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Pharma / Biotech, Trends
Biotech venture firms continue ‘recalibration’ in third quarter, Pitchbook report finds
Forbes names 30 under 30 in healthcare
Insilico Medicine Launches First-in-Human Trial for AI-Discovered IBD Drug
How to Choose the Right Distribution Partner
Listen: CRISPR history, biotech struggles, & a big week for deals

Share This Article